Tesla & Moderna are among the high-flying Nasdaq names in 2020, but shares of diabetes management innovator Dexcom have nearly doubled this year too. We talk to CEO Kevin Sayer about what’s driving company growth. Plus, Apple is reportedly set to launch a series of consumer subscription bundles, including virtual fitness classes. Can it compete with the likes of Peloton & Nike in the exercise sector? We debate in Rapid Fire. And, is the private sector the solution to solving the COVID-19 testing crisis? We ask expert Dr. Michael Osterholm, who gives the U.S. a failing grade in our efforts thus far.

With the S&P 500 just points away from its all-time intraday high, we take a look at whether there is more positive momentum for stocks and where to put money to work. And, Russia approving a Covid vaccine for the public without completing a Phase III trial and without any studies published by researchers...the Director of the Vaccine Education Center at the Children's Hospital of Philadelphia weighs in on the safety issues and how that could disrupt the global race for a vaccine. Plus, the pandemic could cancel the fall season for college sports, leaving colleges without billions in revenue. A top expert weighs in on the wide-spread ramifications.